GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Sphere 347700.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

14,000

-2.85%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in KRW, from our data supplier.

FY2025

Revenue

₩95.64bn

FY2017FY2025

Net income

₩170.3m

FY2017FY2025

Free cash flow

−₩14.71bn

FY2017FY2025

Shareholders' equity

₩63.63bn

FY2017FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue₩95.64bn₩2.56bn₩1.65bn₩2.82bn₩4.63bn₩2.67bn₩1.16bn₩691.0m₩2.41bn
Research and development₩375.1m₩481.4m₩529.8m₩470.5m₩349.9m₩243.3m———
Operating income₩9.05bn−₩13.92bn−₩9.31bn−₩5.61bn−₩6.04bn−₩3.66bn−₩3.58bn−₩2.87bn₩2.41bn
Net income₩170.3m−₩17.50bn−₩11.26bn−₩3.35bn−₩6.22bn−₩9.31bn−₩3.96bn−₩3.70bn₩1.76bn
Diluted earnings per share3.58-794.08-719.08-292.81-549.28-1,064.23-405.38-378.42179.76

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets₩95.36bn₩44.64bn₩19.03bn₩26.13bn₩33.29bn₩9.54bn₩6.26bn₩8.21bn₩2.86bn
Cash and short-term investments—₩19.37bn₩6.26bn₩15.57bn₩26.14bn₩5.51bn₩1.66bn₩7.03bn₩806.7m
Total liabilities₩31.72bn₩13.39bn₩10.06bn₩16.56bn₩20.23bn₩7.35bn₩9.79bn₩7.60bn₩4.69bn
Debt—₩3.90bn₩4.85bn₩7.66bn₩5.22bn₩2.98bn₩5.36bn₩3.29bn₩2.52bn
Shareholders' equity₩63.63bn₩31.25bn₩8.98bn₩9.57bn₩13.06bn₩2.19bn−₩3.53bn₩607.4m−₩1.84bn
Shares outstanding48m22m16m11m11m9m10m10m10m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations−₩14.67bn−₩5.80bn−₩10.27bn−₩5.12bn−₩5.07bn−₩1.27bn−₩3.35bn−₩2.00bn−₩3.98bn
Capital spending−₩46.1m−₩537.3m−₩310.8m−₩182.3m−₩653.2m−₩320.1m−₩462.1m−₩84.1m−₩65.8m
Free cash flow−₩14.71bn−₩6.34bn−₩10.59bn−₩5.30bn−₩5.72bn−₩1.59bn−₩3.82bn−₩2.09bn−₩4.04bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₩77.06bn₩45.07bn₩33.83bn₩21.10bn₩18.86bn₩21.85bn−₩3.45bn₩1.26bn
Operating income₩1.67bn₩710.7m₩3.64bn−₩989.6m—₩4.31bn₩1.31bn−₩1.77bn
Net income−₩24.29bn₩39.79bn−₩20.87bn−₩3.31bn₩21.19bn₩3.16bn−₩9.24bn−₩1.83bn
Diluted earnings per share-516.61837.47-439.29-93.50597.9891.18-419.41-91.63
Cash from operations₩10.22bn−₩32.00bn₩3.90bn−₩7.53bn−₩21.72bn₩10.68bn−₩5.80bn−₩5.87bn
Capital spending−₩46.0m−₩2.0m—−₩2.81bn——−₩537.0m−₩347.0m
Free cash flow₩10.17bn−₩32.01bn—−₩10.33bn——−₩6.34bn−₩6.22bn
Total assets₩585.86bn₩511.23bn₩95.36bn₩120.36bn₩120.67bn₩108.50bn₩44.64bn₩16.17bn
Cash and short-term investments——————₩19.37bn₩5.10bn
Debt₩314.64bn—————₩237.8m₩2.59bn
Shareholders' equity₩163.52bn₩102.38bn₩63.63bn₩67.50bn₩70.81bn₩54.63bn₩31.25bn₩8.92bn

Financial ratios

Data as of 27 Aug 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Operating margin9.5%-544.2%-563.9%-199.0%-130.3%-137.2%—
Net margin0.2%-684.2%-682.1%-118.8%-134.1%-349.2%—
Return on equity0.3%-56.0%-125.5%-35.0%-47.6%-425.8%—
Return on assets0.2%-39.2%-59.2%-12.8%-18.7%-97.6%—
Revenue growth3639.2%54.9%-41.4%-39.2%73.9%129.4%—
Earnings growth-101.0%55.4%236.4%-46.1%-33.2%134.9%—
Current ratio2.45x2.92x1.18x1.17x11.69x2.27x—
Debt to equity—0.00x0.01x0.01x0.33x0.64x-0.55x
Equity ratio66.7%70.0%47.2%36.6%39.2%22.9%—
Interest coverage2.43x-26.51x-5.58x-4.47x-19.93x-8.17x—
R&D as a share of sales0.4%18.8%32.1%16.7%7.5%9.1%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue223.7%104.6%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Price to earnings—-5.0-3.1-12.2-15.1
Price to sales7.334.121.514.520.3

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 3255-for-2909 split · 1 Nov 2023

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.